Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratio

[1]  R. Kreis,et al.  Effects of physiologic motion of the human brain upon quantitative 1H‐MRS: analysis and correction by retro‐gating , 1998, NMR in biomedicine.

[2]  W M Brooks,et al.  Reproducibility of 1H‐MRS in vivo , 1999, Magnetic resonance in medicine.

[3]  P. Pattany,et al.  Effects of physiologic human brain motion on proton spectroscopy: quantitative analysis and correction with cardiac gating. , 2002, AJNR. American journal of neuroradiology.

[4]  P G Webb,et al.  Automated single‐voxel proton MRS: Technical development and multisite verification , 1994, Magnetic resonance in medicine.

[5]  C. Lyketsos,et al.  Long-term outcomes of galantamine treatment in patients with Alzheimer disease. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[6]  E Adalsteinsson,et al.  Motion correction and lipid suppression for 1H magnetic resonance spectroscopy , 2000, Magnetic resonance in medicine.

[7]  R. Moats,et al.  Evaluation of automated MR spectroscopy: application in Alzheimer disease. , 1995, AJNR. American journal of neuroradiology.

[8]  R. Menon,et al.  Comparison of the quantification precision of human short echo time 1H spectroscopy at 1.5 and 4.0 Tesla , 2000, Magnetic resonance in medicine.

[9]  M Slifstein,et al.  Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  D M Doddrell,et al.  A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. , 1999, Magnetic resonance imaging.

[11]  Douglas L. Rothman,et al.  In vivo detection and quantification of scalar coupled H NMR resonances , 2001 .

[12]  P. Williamson,et al.  The use of a priori knowledge to quantify short echo in vivo 1h mr spectra , 1995, Magnetic resonance in medicine.

[13]  P. Allen,et al.  Motional degradation of metabolite signal strengths when using STEAM: A correction method , 1992, NMR in biomedicine.

[14]  Xin Yu,et al.  Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. , 2003, The American journal of psychiatry.

[15]  E G Tangalos,et al.  Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.

[16]  B D Ross,et al.  Probable Alzheimer disease: diagnosis with proton MR spectroscopy. , 1995, Radiology.

[17]  T. Ogino,et al.  Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains. , 1999, Radiation medicine.

[18]  B. Ross,et al.  Added Value of Automated Clinical Proton MR Spectroscopy of the Brain , 1995, Journal of computer assisted tomography.

[19]  G Helms,et al.  Restoration of motion‐related signal loss and line‐shape deterioration of proton MR spectra using the residual water as intrinsic reference , 2001, Magnetic resonance in medicine.

[20]  B D Ross,et al.  Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. , 1993, Radiology.

[21]  I. Marshall,et al.  Reproducibility of metabolite peak areas in 1H MRS of brain. , 1996, Magnetic resonance imaging.

[22]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[23]  Juan Bustillo,et al.  Reproducibility of 1H‐MRS measurements in schizophrenic patients , 2003, Magnetic resonance in medicine.

[24]  T. Ernst,et al.  Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease , 1994, Magnetic resonance in medicine.

[25]  G. Elbel,et al.  Phase coherent averaging in magnetic resonance spectroscopy using interleaved navigator scans: Compensation of motion artifacts and magnetic field instabilities , 2002, Magnetic resonance in medicine.